Jump to content

INTEGRATED DNA TECHNOLOGIES, INC. Patent Application Trends in 2024

From WikiPatents

Revision as of 07:11, 16 July 2024 by Unknown user (talk) (Updating INTEGRATED DNA TECHNOLOGIES, INC._Patent_Application_Trends_in_2024)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

INTEGRATED DNA TECHNOLOGIES, INC. Patent Filing Activity

INTEGRATED DNA TECHNOLOGIES, INC. patent applications in 2024

Top 10 Technology Areas

C07K1/36 (No explanation available)
- Count: 1 patents
- Example: 20240199691. EXPRESSION AND PURIFICATION OF CAS ENZYMES simplified abstract (INTEGRATED DNA TECHNOLOGIES, INC.)
C07K1/18 (No explanation available)
- Count: 1 patents
- Example: 20240199691. EXPRESSION AND PURIFICATION OF CAS ENZYMES simplified abstract (INTEGRATED DNA TECHNOLOGIES, INC.)
C07K1/22 (No explanation available)
- Count: 1 patents
- Example: 20240199691. EXPRESSION AND PURIFICATION OF CAS ENZYMES simplified abstract (INTEGRATED DNA TECHNOLOGIES, INC.)
C12N9/22 (No explanation available)
- Count: 1 patents
- Example: 20240199691. EXPRESSION AND PURIFICATION OF CAS ENZYMES simplified abstract (INTEGRATED DNA TECHNOLOGIES, INC.)
C12Y301/00 (No explanation available)
- Count: 1 patents
- Example: 20240199691. EXPRESSION AND PURIFICATION OF CAS ENZYMES simplified abstract (INTEGRATED DNA TECHNOLOGIES, INC.)
C07K14/47 (No explanation available)
- Count: 1 patents
- Example: 20240059747. UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR simplified abstract (Integrated DNA Technologies, Inc.)
C12N15/86 (No explanation available)
- Count: 1 patents
- Example: 20240059747. UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR simplified abstract (Integrated DNA Technologies, Inc.)
C12N15/907 (No explanation available)
- Count: 1 patents
- Example: 20240059747. UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR simplified abstract (Integrated DNA Technologies, Inc.)
C12N2750/14143 (No explanation available)
- Count: 1 patents
- Example: 20240059747. UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR simplified abstract (Integrated DNA Technologies, Inc.)
C12Q1/6806 (No explanation available)
- Count: 1 patents
- Example: 20240068011. NORMALIZATION OF NGS LIBRARY CONCENTRATION simplified abstract (Integrated DNA Technologies, Inc.)

Emerging Technology Areas

C40B40/08 (No explanation available)
- Count: 1 patents
- Example: 20240068011. NORMALIZATION OF NGS LIBRARY CONCENTRATION simplified abstract (Integrated DNA Technologies, Inc.)
C12Q1/6876 (No explanation available)
- Count: 1 patents
- Example: 20240068011. NORMALIZATION OF NGS LIBRARY CONCENTRATION simplified abstract (Integrated DNA Technologies, Inc.)
C12Q1/686 (No explanation available)
- Count: 1 patents
- Example: 20240068011. NORMALIZATION OF NGS LIBRARY CONCENTRATION simplified abstract (Integrated DNA Technologies, Inc.)
C12N15/00 (No explanation available)
- Count: 1 patents
- Example: 20240068011. NORMALIZATION OF NGS LIBRARY CONCENTRATION simplified abstract (Integrated DNA Technologies, Inc.)
C12Q1/6806 (No explanation available)
- Count: 1 patents
- Example: 20240068011. NORMALIZATION OF NGS LIBRARY CONCENTRATION simplified abstract (Integrated DNA Technologies, Inc.)
C12N2750/14143 (No explanation available)
- Count: 1 patents
- Example: 20240059747. UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR simplified abstract (Integrated DNA Technologies, Inc.)
C12N15/907 (No explanation available)
- Count: 1 patents
- Example: 20240059747. UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR simplified abstract (Integrated DNA Technologies, Inc.)
C12N15/86 (No explanation available)
- Count: 1 patents
- Example: 20240059747. UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR simplified abstract (Integrated DNA Technologies, Inc.)
C07K14/47 (No explanation available)
- Count: 1 patents
- Example: 20240059747. UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR simplified abstract (Integrated DNA Technologies, Inc.)
C12Y301/00 (No explanation available)
- Count: 1 patents
- Example: 20240199691. EXPRESSION AND PURIFICATION OF CAS ENZYMES simplified abstract (INTEGRATED DNA TECHNOLOGIES, INC.)

Top Inventors

Sarah Franz BEAUDOIN of Coralville IA (US) (1 patent)
Michael Allen COLLINGWOOD of Coralville IA (US) (1 patent)
Christopher Anthony VAKULSKAS of Coralville IA (US) (1 patent)
Mark Aaron BEHLKE of Coralville IA (US) (1 patent)
Steve Ehren Glenn of North Liberty IA (US) (1 patent)
Michael Allen Collingwood of Solon IA (US) (1 patent)
Christopher Anthony Vakulskas of North Liberty IA (US) (1 patent)
Vladimir Makarov of Ann Arbor MI (US) (1 patent)
Sergey Chupreta of Gregory MI (US) (1 patent)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors

Retrieved from "https://wikipatents.org/index.php?title=INTEGRATED_DNA_TECHNOLOGIES,_INC._Patent_Application_Trends_in_2024&oldid=115448"

Cookies help us deliver our services. By using our services, you agree to our use of cookies.